A detailed history of Paragon Wealth Strategies, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Paragon Wealth Strategies, LLC holds 378 shares of LLY stock, worth $290,213. This represents 0.06% of its overall portfolio holdings.

Number of Shares
378
Holding current value
$290,213
% of portfolio
0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 03, 2024

BUY
$525.19 - $619.13 $198,521 - $234,031
378 New
378 $220,000
Q4 2022

Jan 27, 2023

BUY
$321.55 - $374.67 $5,787 - $6,744
18 Added 81.82%
40 $14,000
Q3 2022

Nov 03, 2022

BUY
$296.48 - $337.87 $6,522 - $7,433
22 New
22 $7,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Paragon Wealth Strategies, LLC Portfolio

Follow Paragon Wealth Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Wealth Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Wealth Strategies, LLC with notifications on news.